Combined-type oral contraceptives and plasma triglyceride and cholesterol levels of young women.
D001695:Biology; D001769:Blood; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D005193:Family Planning Services; D008055:Lipids; D008656:Mestranol; D009640:Norethindrone; D009641:Norethynodrel; D010827:Physiology; D012106:Research
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D003278:Contraceptives, Oral, Hormonal; D008055:Lipids; D009641:Norethynodrel; D008656:Mestranol; D009640:Norethindrone
Biology; Clinical Research; Comparative Studies; Contraception; Contraceptive Agents, Estrogen--administraction and dosage; Contraceptive Agents, Estrogen--side effects; Contraceptive Agents, Female--administraction and dosage; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--administraction and dosage; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--administraction and dosage; Contraceptive Agents--side effects; Contraceptive Methods--side effects; Family Planning; Hematological Effects; Hemic System; Lipid Metabolic Effects; Lipids; Mestranol--administraction and dosage; Mestranol--side effects; Norethindrone--administraction and dosage; Norethindrone--side effects; Norethynodrel; Oral Contraceptives, Combined; Oral Contraceptives--side effects; Physiology; Research Methodology; Studies